• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在人体皮肤中,大麻素受体激动剂可减弱组胺诱导的反应。

Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin.

作者信息

Dvorak M, Watkinson A, McGlone F, Rukwied R

机构信息

Unilever Research & Development Port Sunlight, Wirral, UK.

出版信息

Inflamm Res. 2003 Jun;52(6):238-45. doi: 10.1007/s00011-003-1162-z.

DOI:10.1007/s00011-003-1162-z
PMID:12835895
Abstract

OBJECTIVE AND DESIGN

In the present study we examined the effects of the cannabinoid receptor agonist HU210 on histamine-evoked somatosensory and vascular responses in humans.

SUBJECTS

Two sets of experiments were performed, in which twelve (Study 1, iontophoresis) and six participants (Study 2, microdialysis) were recruited.

TREATMENT

HU210 was administered peripherally by skin patch (50 mM) or dermal microdialysis (5 mM), whereas histamine was applied by iontophoresis (50 microAmps) or dermal microdialysis (5 microM).

METHODS

Skin blood flow was monitored by laser Doppler, widespread flare reaction was evaluated planimetrically, extravasation of plasma proteins was measured in the dialysate and perceived itch was recorded using a visual analogue scale. Data were evaluated by analysis of variance.

RESULTS

Experimentally induced itch was significantly reduced by peripheral administration of HU210 (p < 0.05). Additionally, skin blood flow and neurogenic mediated flare responses were attenuated (p < 0.003 and p < 0.03, respectively), whereas protein extravasation due to histamine was enhanced by co-administration of HU210, as investigated by dermal microdialysis.

CONCLUSIONS

In humans peripheral administration of a cannabinoid receptor agonist attenuates histamine-induced itch. The observation that protein extravasation was not decreased demonstrates that the alleviation of itch is not due to an anti-histaminergic property of HU210. The reduced neurogenic flare reaction indicates an attenuated antidromic nerve fibre activation and neuropeptide release.

摘要

目的与设计

在本研究中,我们检测了大麻素受体激动剂HU210对人体组胺诱发的体感和血管反应的影响。

受试者

进行了两组实验,招募了12名参与者(研究1,离子导入法)和6名参与者(研究2,微透析法)。

治疗

HU210通过皮肤贴片(50 mM)或皮肤微透析(5 mM)进行外周给药,而组胺通过离子导入法(50微安)或皮肤微透析(5微摩尔)给药。

方法

用激光多普勒监测皮肤血流,用平面测量法评估广泛的潮红反应,在透析液中测量血浆蛋白外渗,并使用视觉模拟量表记录感觉到的瘙痒。数据通过方差分析进行评估。

结果

外周给予HU210可显著减轻实验诱导的瘙痒(p < 0.05)。此外,皮肤血流和神经源性介导的潮红反应减弱(分别为p < 0.003和p < 0.03),而通过皮肤微透析研究发现,HU210联合给药可增强组胺引起的蛋白外渗。

结论

在人体中,外周给予大麻素受体激动剂可减轻组胺诱发的瘙痒。蛋白外渗未降低的观察结果表明,瘙痒的缓解并非由于HU210的抗组胺特性。神经源性潮红反应的减弱表明逆行性神经纤维激活和神经肽释放减弱。

相似文献

1
Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin.在人体皮肤中,大麻素受体激动剂可减弱组胺诱导的反应。
Inflamm Res. 2003 Jun;52(6):238-45. doi: 10.1007/s00011-003-1162-z.
2
Nedocromil sodium inhibits histamine-induced itch and flare in human skin.奈多罗米钠可抑制组胺诱导的人体皮肤瘙痒和潮红。
Br J Pharmacol. 2001 Feb;132(3):613-6. doi: 10.1038/sj.bjp.0703852.
3
Flare Size but Not Intensity Reflects Histamine-Induced Itch.瘙痒程度而非强度反映了组胺诱导的瘙痒。
Skin Pharmacol Physiol. 2020;33(5):244-252. doi: 10.1159/000508795. Epub 2020 Oct 26.
4
Acute effects of substance P and calcitonin gene-related peptide in human skin--a microdialysis study.P物质和降钙素基因相关肽对人体皮肤的急性作用——一项微透析研究
J Invest Dermatol. 2000 Dec;115(6):1015-20. doi: 10.1046/j.1523-1747.2000.00142.x.
5
Investigation into the mechanisms by which nedocromil sodium, frusemide and bumetanide inhibit the histamine-induced itch and flare response in human skin in vivo.对奈多罗米钠、呋塞米和布美他尼在体内抑制组胺诱导的人体皮肤瘙痒和潮红反应机制的研究。
Clin Exp Allergy. 2004 Mar;34(3):450-5. doi: 10.1111/j.1365-2222.2004.01898.x.
6
Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin.A型肉毒毒素可减轻组胺诱导的人类皮肤瘙痒和血管运动反应。
Br J Dermatol. 2009 Oct;161(4):737-45. doi: 10.1111/j.1365-2133.2009.09305.x. Epub 2009 May 11.
7
Correlations between histamine-induced wheal, flare and itch.组胺诱导的风团、潮红与瘙痒之间的相关性。
Arch Dermatol Res. 1996 Jul;288(8):436-41. doi: 10.1007/BF02505231.
8
Recovery of nitric oxide from acetylcholine-mediated vasodilatation in human skin in vivo.体内人体皮肤中从乙酰胆碱介导的血管舒张中回收一氧化氮
Microcirculation. 2004 Apr-May;11(3):249-59. doi: 10.1080/10739680490425958.
9
No release of histamine and substance P in capsaicin-induced neurogenic inflammation in intact human skin in vivo: a microdialysis study.体内完整人体皮肤中辣椒素诱导的神经源性炎症中组胺和P物质无释放:一项微透析研究。
Clin Exp Allergy. 1997 Aug;27(8):957-65.
10
Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin.地氯雷他定和左西替利嗪对组胺诱导的人体皮肤风团、潮红及瘙痒作用的比较。
Inflamm Res. 2003 Oct;52(10):424-7. doi: 10.1007/s00011-003-1193-5.

引用本文的文献

1
European S2k Guideline on Chronic Pruritus.欧洲慢性瘙痒症S2k指南。
Acta Derm Venereol. 2025 Aug 22;105:adv44220. doi: 10.2340/actadv.v105.44220.
2
Electroacupuncture exerts antipruritic and anti-inflammatory effects on atopic dermatitis by activating CB2 receptor.电针通过激活CB2受体对特应性皮炎发挥止痒和抗炎作用。
Chin Med. 2025 May 26;20(1):72. doi: 10.1186/s13020-025-01102-4.
3
New Horizons in Dermal and Transdermal Drug Delivery Systems.皮肤和透皮给药系统的新进展
Pharmaceuticals (Basel). 2023 Nov 28;16(12):1654. doi: 10.3390/ph16121654.
4
Cannabinoids and Their Receptors in Skin Diseases.大麻素及其在皮肤疾病中的受体。
Int J Mol Sci. 2023 Nov 20;24(22):16523. doi: 10.3390/ijms242216523.
5
Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases.大麻素化合物作为治疗非癌症皮肤疾病的一种药物治疗选择。
Cells. 2022 Dec 16;11(24):4102. doi: 10.3390/cells11244102.
6
Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects.具有镇痛和止痒作用的可成药靶点及化合物
Pharmaceuticals (Basel). 2022 Jul 19;15(7):892. doi: 10.3390/ph15070892.
7
Topical cannabidiol (CBD) in skin pathology - A comprehensive review and prospects for new therapeutic opportunities.局部应用大麻二酚(CBD)在皮肤病理学中的应用——全面综述及新治疗机会展望。
S Afr Fam Pract (2004). 2022 May 30;64(1):e1-e4. doi: 10.4102/safp.v64i1.5493.
8
Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review.用于治疗皮肤炎症性疾病的大麻基产品:及时综述
Pharmaceuticals (Basel). 2022 Feb 9;15(2):210. doi: 10.3390/ph15020210.
9
Cannabinoids for the Treatment of Dermatologic Conditions.用于治疗皮肤病的大麻素类药物。
JID Innov. 2022 Jan 13;2(2):100095. doi: 10.1016/j.xjidi.2022.100095. eCollection 2022 Mar.
10
Neuropathic itch treated with oral cannabinoids: A case series.口服大麻素治疗神经性瘙痒:病例系列
JAAD Case Rep. 2021 Sep 20;17:38-42. doi: 10.1016/j.jdcr.2021.09.006. eCollection 2021 Nov.